Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
ELOVL6-IN-5
Cat. No.:
OB0425LY-218
Appearance:
Solid
Purity:
95.12%
Identity:
Confirmed by NMR, HPLC, and MS.
Size:
Add to basket
Product Overview
Description:
ELOVL6-IN-5 is a potent elongase enzyme of long-chain fatty acid family 6 (ELOVL6) inhibitor.
Synonyms:
1170321-92-2; 3-(Pyridin-2-ylsulfonyl)-N-(4-(trifluoromethyl)phenyl)-8-azabicyclo[3.2.1]octane-8-carboxamide; 3-Pyridin-2-ylsulfonyl-N-[4-(trifluoromethyl)phenyl]-8-azabicyclo[3.2.1]octane-8-carboxamide; 3-(Pyridin-2-ylsulfonyl)-N-(4-(trifluoromethyl)phenyl)-8-azabicyclo[3.2.1]octane-8-carboxamide-endo
CAS No.:
1135000-36-0
Compound CID:
25234001
Formula:
C20H20F3N3O3S
Formula Weight:
439.45
Specification
Target:
ELOVL
Pathway:
Others
Storage:
Storage at -20°C.
Applications:
ELOVL6-IN-5 can be used to explore diseases related to lipid metabolism, such as obesity, type 2 diabetes and fatty liver disease.
